Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial

被引：0

作者：

Oliva, E. N. ^{[1
]}

Santini, V. ^{[2
]}

Zini, G. ^{[3
]}

Palumbo, G. A. ^{[4
]}

Poloni, A. ^{[5
]}

Cortelezzi, A. ^{[6
]}

Rodeghiero, F. ^{[7
]}

Voso, M. T. ^{[8
]}

Molteni, A. ^{[9
]}

Sanpaolo, G. ^{[10
]}

Liberati, M. ^{[11
]}

Morabito, F. ^{[12
]}

Balleari, E. ^{[13
]}

Impera, S. ^{[14
]}

Salvi, F. ^{[15
]}

Spiriti, M. A. Aloe ^{[16
]}

Marino, A. ^{[1
]}

Roda, F. ^{[1
]}

Alati, C. ^{[1
]}

Ronco, F. ^{[1
]}

Di Raimondo, F. ^{[4
]}

Leoni, P. ^{[5
]}

Alimena, G. ^{[17
]}

Latagliata, R. ^{[17
]}

Nobile, F. ^{[1
]}

机构：

[1] Azienda Osped Bianchi Melacrino Morelli, Hematol Unit, Reggio Di Calabria, Italy

[2] Univ Florence, Clin Ematol & Oncol, Florence, Italy

[3] Univ Cattolica Sacro Cuore, Hematol Lab, I-00168 Rome, Italy

[4] AOU Policlin V Emanuele, Hematol Unit, Catania, Italy

[5] Torrette Hosp, Div Hematol & Oncol, Ancona, Italy

[6] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Hematol, Milan, Italy

[7] San Bortolo Hosp, Dept Cell Therapy & Hematol, Vicenza, Italy

[8] Policlin Gemelli, Dept Hematol, Rome, Italy

[9] Osped Niguarda Ca Granda, Div Hematol, Milan, Italy

[10] Casa Sollievo Sofferenza Hosp, Div Hematol, San Giovanni Rotondo, Italy

[11] AO S Maria Policlinico Monteluce, Div Hematol, Terni, Italy

[12] Azienda Osped Annunziata, Dept Oncohematol, Cosenza, Italy

[13] IRCCS, Azienda Osped Univ San Martino, Dept Oncohematol, Genoa, Italy

[14] Presidio Osped Garibaldi Nesima, Hematol Unit, Catania, Italy

[15] Azienda Osped SS Antonio & Biagio & C Arrigo, Dept Oncohematol, Alessandria, Italy

[16] Azienda Osped St Andrea, Dept Hematol, Rome, Italy

[17] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy

来源：

LEUKEMIA RESEARCH | 2013年 / 37卷

关键词：

D O I：

10.1016/S0145-2126(13)70357-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-310

引用

页码：S162 / S162

页数：1

共 50 条

[1] ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A PROSPECTIVE, RANDOMIZED, TRIAL
Oliva, E.
Santini, V.
Zini, G.
Palumbo, G.
Poloni, A.
Cortelezzi, A.
Rodeghiero, F.
Voso, M.
Molteni, A.
Sanpaolo, G.
Liberati, A.
Morabito, F.
Balleari, E.
Impera, S.
Salvi, F.
Spiriti, M.
Marino, A.
Roda, F.
Alati, C.
Ronco, F.
Raimondo, F.
Leoni, P.
Alimena, G.
Fioritoni, G.
Latagliata, R.
Nobile, F.
[J]. HAEMATOLOGICA, 2013, 98 : 456 - 456
[2] Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Results on Efficacy, Safety and Quality of Life of an International, Multicenter Prospective, Randomized, Trial
Oliva, Esther Natalie
Santini, Valeria
Alati, Caterina
Poloni, Antonella
Molteni, Alfredo
Niscola, Pasquale
Sanpaolo, Grazia
Salvi, Flavia
Palumbo, Giuseppe A.
Balleari, Enrico
Impera, Stefana
Cortelezzi, Agostino
Liberati, Anna Marina
Avanzini, Paolo
Di Bartolomeo, Paolo
Rose, Christian
Beyne-Rauzy, Odile
Buccisano, Francesco
Bocchia, Monica
Morabito, Fortunato
Stamatoullas, Aspasia
Ronco, Francesca
Zini, Gina
D'Errigo, Maria Grazia
Ranieri, Natale
Cufari, Patrizia
Santacaterina, Irene
Fenaux, Pierre
Latagliata, Roberto
[J]. BLOOD, 2015, 126 (23)
[3] Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)
Oliva, Esther Natalie
Santini, Valeria
Zini, Gina
Palumbo, Giuseppe A.
Poloni, Antonella
Cortelezzi, Agostino
Voso, Maria Teresa
Molteni, Alfredo
Sanpaolo, Grazia
Marino, Antonio
Roda, Filippo
Alati, Caterina
Ronco, Francesca
Di Raimondo, Francesco
Leoni, Pietro
Alimena, Giuliana
Finotto, Silvia
Latagliata, Roberto
Nobile, Francesco
[J]. BLOOD, 2012, 120 (21)
[4] 5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
Musto, Luca Maurillo
Spagnoli, Alessandra
Gozzini, Antonella
Rivellini, Flavia
Tatarelli, Caterina
Lunghi, Monia
Fili, Carla
Orciuolo, Enrico
Ciuffreda, Lucia
Vigna, Ernesto
Della Cioppa, Paola
Candoni, Anna
Ferrero, Dario
Palmieri, Salvatore
Palumbo, Giuseppe
Di Renzo, Nicola
Oliva, Esther
Sanpaolo, Grazia
Pastore, Domenico
Tonso, Anna
Santagostino, Alberto
Rocco, Stefano
Villani, Oreste
D'Auria, Fiorella
D'Arco, Alfonso Maria
Gaidano, Gianluca
Galimberti, Sara
Russo, Domenico
Venditti, Adriano
Aloe-Spiriti, Maria Antonietta
Leone, Giuseppe
Santini, Valeria
[J]. BLOOD, 2008, 112 (11) : 926 - 927
[5] 5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
Musto, P.
Maurillo, L.
Spagnoli, A.
Gozzini, A.
Rivellini, F.
Tatarelli, C.
Lunghi, M.
Fili, C.
Orciuolo, E.
Ciuffreda, L.
Vigna, E.
Della Cioppa, P.
Ferrero, D.
Palmieri, S.
Palumbo, G.
Di Renzo, N.
Oliva, E.
Sanpaolo, G.
Pastore, D.
Tonso, A.
Santagostino, A.
Villani, O.
D'Auria, F.
D'Arco, A.
Gaidano, G.
Galimberti, S.
Russo, D.
Venditti, A.
Aloe-Spiriti, M. A.
Leone, G.
Santini, V.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 368 - 368
[6] The in vitro effect of SB-497115 (Eltrombopag) on megakaryopoiesis of patients with low/intermediate-1 IPSS myelodysplastic syndrome
Papadaki, H.
Mavroudi, I.
Psyllaki, M.
Pyrovolaki, K.
Papadaki, V.
Kalpadakis, C.
Mastrodimou, S.
Kaparou, M.
Kanellou, P.
Gvazava, G.
[J]. LEUKEMIA RESEARCH, 2009, 33 : S47 - S48
[7] OUTCOMES OF CONTINUED AZACITIDINE TREATMENT FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME IN IPSS LOW AND INTERMEDIATE-1
Moon, J. H.
Sohn, S. K.
Cho, Y. Y.
Kim, Y. K.
Kim, H. J.
Kim, M. K.
Do, Y. R.
Song, M. K.
Lee, W. K.
Lee, S. M.
Kim, H.
Won, J. H.
Yeon, J. Deok
[J]. HAEMATOLOGICA, 2012, 97 : 141 - 141
[8] QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED PROSPECTIVE TRIAL
Oliva, E. N.
Santini, V.
Alati, C.
Sanpaolo, G.
Poloni, A.
Molteni, A.
Ronco, F.
Palumbo, G.
Marino, A.
Impera, S.
Balleari, E.
Salutari, P.
Cufari, P.
Santacaterina, I.
Avanzini, P.
Niscola, P.
Liberati, A. M.
Ricco, A.
Morabito, F.
Cortelezzi, A.
Fianchi, L.
Buccisano, F.
Fenaux, P.
Beyne-Rauzy, O.
Rodeghiero, F.
Salvi, F.
Latagliata, R.
[J]. HAEMATOLOGICA, 2015, 100 : 575 - 576
[9] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry
Schmitz, S.
Boettger, I
Schnell, R.
Lerchenmueller, C.
Sauer, A.
Severin, K.
Germing, U.
Steinmetz, H. T.
[J]. ONKOLOGIE, 2012, 35 : 148 - 148
[10] Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study
Villegas, Ana
Arrizabalaga, B.
Fernandez-lago, C.
Mouzo, M.
Mayans, Jr
Gonalez-Porras, Jr
Duarte, Rafael
Remacha, Angel Francisco
Luno, Elisa
Gasquet, J. A.
[J]. BLOOD, 2008, 112 (11) : 1184 - 1184

← 1 2 3 4 5 →